Thursday, November 6, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Options Activity Indicates Mixed Sentiments Among WellFunded Investors in FedEx

Elaine Mendonca by Elaine Mendonca
March 4, 2024
in Breaking News
0
Logistics Stock Market Today (2)
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

We have seen a surge in interest from well-funded investors in FedEx (NYSE: FDX) with some interesting options activity taking place. It appears that there is a mix of both bullish and bearish sentiments among these investors.

One notable trade that caught our attention was a bullish put trade set to expire on 03/15/24 with a strike price of $247.50. Additionally, a bullish call sweep expiring on 06/21/24 at a strike price of $250.00 was also observed.

This increase in options activity may indicate potential upcoming events or shifts in investor sentiment towards FedEx. Looking at the volume and open interest trends over the last 3 months, it seems that investors have been eyeing a price range of $220.0 to $300.0 for FedEx.

It will be interesting to see how these options trades play out and what they may signal for the future of FedEx.

FedEx (FDX) Stock Update: March 4, 2024 – Slight Increase but Below 200-Day Moving Average

On March 4, 2024, FedEx (FDX) stock closed at $246.78, showing a slight increase of $0.18 or 0.07% since the market last closed. However, in after-hours trading, the stock dropped $0.01.

Despite the slight increase in price, FDX is still below its 200-day simple moving average, indicating that the stock may be facing some resistance in its upward momentum.

The fact that FDX is trading in the middle of its 52-week range suggests that the stock is neither overbought nor oversold at the moment.

Overall, the performance of FDX stock on March 4, 2024, was relatively flat with a slight increase in price but still below its 200-day simple moving average. Investors should keep an eye on how the stock performs in the coming days to see if it can break through this resistance and continue its upward trend.

FedEx Corporation (FDX) Stock Performance Analysis: March 4, 2024

On March 4, 2024, FedEx Corporation (FDX) stock performance was closely watched by investors and analysts following the release of its latest financial data. According to CNN Money, the company reported a total revenue of $90.16 billion for the past year, which represents a 3.59% decrease compared to the previous year. In the second quarter, total revenue was $22.16 billion, holding flat compared to the previous quarter.

Despite the decrease in total revenue, FedEx managed to increase its net income to $3.97 billion for the past year, marking a 3.85% increase from the previous year. However, net income decreased by 16.62% in the second quarter to $898.00 million.

Earnings per share (EPS) also saw fluctuations in performance. The company reported an EPS of $15.49 for the past year, showing a 7.91% increase from the previous year. However, EPS decreased by 16.29% in the second quarter to $3.55.

Overall, FedEx’s financial performance on March 4, 2024, showed mixed results. While the company managed to increase its net income and EPS on a yearly basis, there were declines in these metrics in the second quarter. The decrease in total revenue compared to the previous year also raised concerns among investors.

Investors will be closely monitoring FedEx’s future performance and strategies to navigate through the challenging market conditions. The company’s ability to adapt to changing consumer behavior and global economic trends will be crucial in determining its stock performance in the coming months.

Tags: FDX
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
TMUS stock news

Insiders Show Strong Belief in Charles Colvard Ltd

Finance_ Charts for stock trading

Analyst Evaluations and Price Targets for Analog Devices NASDAQ ADI

Entertainment Trading online

Netflixs Triumph A ForwardThinking Approach to Streaming Success

Recommended

Baidu Stock

Baidu’s Strategic Moves in Autonomous Driving and AI Draw Mixed Investor Reactions

1 month ago

Windtree Therapeutics Achieves Financial Stability and Advances Clinical Programs

2 years ago
Technology Data analytics Stock Bull Market

Anticipation High for Adobes FirstQuarter Financial Results and AI Innovation

2 years ago
Ideaya Biosciences Stock

Ideaya Biosciences: A Tale of Market Skepticism and Clinical Promise

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

EU Grant Provides Critical Boost for LanzaTech’s Carbon Recycling Technology

Is Darden Restaurants Facing a Critical Test?

Critical Juncture for USA Rare Earth as Earnings and Chinese Export Curbs Collide

AES Shares Surge on Potential $38 Billion Acquisition Speculation

Kura Oncology Investors Await Crucial FDA Verdict

Cadence Design Stock: A Battle Between Fundamentals and Market Signals

Trending

DuPont de Nemours Stock
Analysis

DuPont Faces Critical Test as Quarterly Results Loom

by Dieter Jaworski
November 6, 2025
0

DuPont de Nemours finds itself at a pivotal moment as the chemical giant prepares to release quarterly...

Sarepta Therapeutics Stock

Sarepta Therapeutics Shares Plummet Following Critical Clinical Trial Failure

November 6, 2025
Emerson Electric Stock

Emerson Electric’s Strategic Pivot Faces Market Scrutiny

November 6, 2025
Lanzatech Global Stock

EU Grant Provides Critical Boost for LanzaTech’s Carbon Recycling Technology

November 6, 2025
Darden Restaurants Stock

Is Darden Restaurants Facing a Critical Test?

November 6, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • DuPont Faces Critical Test as Quarterly Results Loom
  • Sarepta Therapeutics Shares Plummet Following Critical Clinical Trial Failure
  • Emerson Electric’s Strategic Pivot Faces Market Scrutiny

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com